SCCF Purpose

Sickle Cell Disease (SCD) affects more people in the world than any other genetic disease. Globally, almost one-half million babies die from SCD each year. We have discovered a treatment that promises permanent relief from the suffering, pain and premature death caused by SCD. We have devised a strong global plan for delivering this treatment […]

MALARIA – SCD

HbF (fetal hemoglobin) suppresses the expression of sickle cell disease. In addition, a recent literature review by the imminent Dr. David Weatherall suggests that HbF protects infants from malaria during the first year of life,until HbF levels decline to modest levels through a normal developmental transition as quoted below: In vitro studies have shown that […]

Global Mission

Sickle cell disease (SCD) is a global problem. As the most common genetic disease in the world, SCD touches the lives of millions and affects many more. People of at least five racial groups and numerous ethnic origins have inherited the sickle gene. SCD is correctly classified as a “tropical disease”, since it is most […]

Corporate Partners

Executive Summaries (outlines) of “More Than Non-Profit”, “Non-Lucratif et Encore”, and “Beyond For-Profit Only” versions of our Business Plans are attached below. The full Business Plans (in three versions) are attached as PDFs below the Executive Summaries. Certified copies will be sent to entities or individuals who respond to our RFPP (Request for Proposals to […]

About SCCF

The Sickle Cell Cure Foundation, Inc. (SCCF) is a nonprofit corporation registered in the State of Oklahoma. Its 501(C) (3) status has been approved by the Internal Revenue Service of the United States as of February 12, 2007. Thus, all donations to the Foundation are tax-deductible. The date of SCCF’s incorporation was July 28, 2006.